Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater

Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of pharmacotherapy 2018-11, Vol.52 (11), p.1162-1164
Hauptverfasser: Rabon, Alyssa D., Fisher, Jon P., MacVane, Shawn H.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1164
container_issue 11
container_start_page 1162
container_title The Annals of pharmacotherapy
container_volume 52
creator Rabon, Alyssa D.
Fisher, Jon P.
MacVane, Shawn H.
description
doi_str_mv 10.1177/1060028018783498
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2056762416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1060028018783498</sage_id><sourcerecordid>2056762416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-2046f6f59595e993f67d57e6e6eef82ab2d8f86e67c931dac7d9ac3535b3e4a13</originalsourceid><addsrcrecordid>eNp1kM1PGzEQxa0KVALtvafKRy4L_ti118cqEBopEggFcVw59rgYdu3U3rRK_3qcBHqoVM1hZvR-86R5CH2h5IJSKS8pEYSwltBWtrxW7Qc0oU3NKsEkOSpzkaudfoJOc34mhCjK1Ed0wpSilCsyQb_nwXgLwQDWweJ7n1_wTJsxpoxdTPgKfkEf1wOEEUeHl08pDqtotmNcQ_Aa-4Dv9OiLnPEygR7B4kc_PuGFD_An9t7ubSS-0tuMy3Szh9IndOx0n-HzWz9DD7Pr5fR7tbi9mU-_LSrDuRwrRmrhhGtUKVCKOyFtI0GUAtcyvWK2dW1ZpVGcWm2kVdrwhjcrDrWm_AydH3zXKf7cQB67wWcDfa8DxE3uGGmEFKymoqDkgJoUc07gunXyg07bjpJuF3f3b9zl5Oub-2Y1gP178J5vAaoDkPUP6J7jJoXy7f8NXwGMeYfk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2056762416</pqid></control><display><type>article</type><title>Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater</title><source>Access via SAGE</source><creator>Rabon, Alyssa D. ; Fisher, Jon P. ; MacVane, Shawn H.</creator><creatorcontrib>Rabon, Alyssa D. ; Fisher, Jon P. ; MacVane, Shawn H.</creatorcontrib><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1177/1060028018783498</identifier><identifier>PMID: 29911390</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><ispartof>The Annals of pharmacotherapy, 2018-11, Vol.52 (11), p.1162-1164</ispartof><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-2046f6f59595e993f67d57e6e6eef82ab2d8f86e67c931dac7d9ac3535b3e4a13</citedby><cites>FETCH-LOGICAL-c337t-2046f6f59595e993f67d57e6e6eef82ab2d8f86e67c931dac7d9ac3535b3e4a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1060028018783498$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1060028018783498$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29911390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rabon, Alyssa D.</creatorcontrib><creatorcontrib>Fisher, Jon P.</creatorcontrib><creatorcontrib>MacVane, Shawn H.</creatorcontrib><title>Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kM1PGzEQxa0KVALtvafKRy4L_ti118cqEBopEggFcVw59rgYdu3U3rRK_3qcBHqoVM1hZvR-86R5CH2h5IJSKS8pEYSwltBWtrxW7Qc0oU3NKsEkOSpzkaudfoJOc34mhCjK1Ed0wpSilCsyQb_nwXgLwQDWweJ7n1_wTJsxpoxdTPgKfkEf1wOEEUeHl08pDqtotmNcQ_Aa-4Dv9OiLnPEygR7B4kc_PuGFD_An9t7ubSS-0tuMy3Szh9IndOx0n-HzWz9DD7Pr5fR7tbi9mU-_LSrDuRwrRmrhhGtUKVCKOyFtI0GUAtcyvWK2dW1ZpVGcWm2kVdrwhjcrDrWm_AydH3zXKf7cQB67wWcDfa8DxE3uGGmEFKymoqDkgJoUc07gunXyg07bjpJuF3f3b9zl5Oub-2Y1gP178J5vAaoDkPUP6J7jJoXy7f8NXwGMeYfk</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Rabon, Alyssa D.</creator><creator>Fisher, Jon P.</creator><creator>MacVane, Shawn H.</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201811</creationdate><title>Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater</title><author>Rabon, Alyssa D. ; Fisher, Jon P. ; MacVane, Shawn H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-2046f6f59595e993f67d57e6e6eef82ab2d8f86e67c931dac7d9ac3535b3e4a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rabon, Alyssa D.</creatorcontrib><creatorcontrib>Fisher, Jon P.</creatorcontrib><creatorcontrib>MacVane, Shawn H.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rabon, Alyssa D.</au><au>Fisher, Jon P.</au><au>MacVane, Shawn H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2018-11</date><risdate>2018</risdate><volume>52</volume><issue>11</issue><spage>1162</spage><epage>1164</epage><pages>1162-1164</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>29911390</pmid><doi>10.1177/1060028018783498</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1060-0280
ispartof The Annals of pharmacotherapy, 2018-11, Vol.52 (11), p.1162-1164
issn 1060-0280
1542-6270
language eng
recordid cdi_proquest_miscellaneous_2056762416
source Access via SAGE
title Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T22%3A55%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20Risk%20Factors%20for%20Development%20of%20Thrombocytopenia%20in%20Patients%20Treated%20With%20Linezolid%20for%207%20Days%20or%20Greater&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Rabon,%20Alyssa%20D.&rft.date=2018-11&rft.volume=52&rft.issue=11&rft.spage=1162&rft.epage=1164&rft.pages=1162-1164&rft.issn=1060-0280&rft.eissn=1542-6270&rft_id=info:doi/10.1177/1060028018783498&rft_dat=%3Cproquest_cross%3E2056762416%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2056762416&rft_id=info:pmid/29911390&rft_sage_id=10.1177_1060028018783498&rfr_iscdi=true